For the cdc it could basically see the viral loads in the air and even map them globally to prevent viral outbreaks that are airborne or not.

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Why use traps and pesticides when you could zap a roach away?

Scalable biofabrication of heart helical tissue pattern augments pumping function.

Michael V. Sefton [email protected] and Craig A. Simmons

Science.

Have you ever desired to possess shoes like in the Back to Future movie? The shoes that tie the laces to fit the feet…

Well, it may not be exactly the same thing, but German company WertelOberfell seems to have managed to create 3D-printed shoes that adapt to your feet.

Researchers create the most realistic rogue waves to date, showing dynamics that follow those expected for extreme waves in more idealized systems.

New users can start creating straight away. Lessons learned from deployment and improvements to our safety systems make wider availability possible.

Sign up

Starting today, we are removing the waitlist for the DALL·E beta so users can sign up and start using it immediately. More than 1.5M users are now actively creating over 2M images a day with DALL·E—from artists and creative directors to authors and architects—with over 100K users sharing their creations and feedback in our Discord community.

Looks like he will be able to do Die Hard 300 and beyond.😄

Earlier this year, Bruce Willis announced he’d be ‘stepping away’ from acting following an aphasia diagnosis.

A disorder that affects how a person communicates, aphasia impacts writing, speech, and how someone understands spoken language.

And although Willis didn’t mention the diagnosis when he confirmed this week that he’d sold his rights, allowing his ‘digital twin’ to be used on screen, it would allow him to keep appearing in films without actually being on set.

The use of immunodetection assays including the widely used enzyme-linked immunosorbent assay (ELISA) in applications such as point-of-care detection is often limited by the need for protein immobilization and multiple binding and washing steps. Here, we describe an experimental and analytical framework for the development of simple and modular “mix-and-read” enzymatic complementation assays based on split luciferase that enable sensitive detection and quantification of analytes in solution. In this assay, two engineered protein binders targeting nonoverlapping epitopes on the target analyte were each fused to nonactive fragments of luciferase to create biosensor probes. Binding proteins to two model targets, lysozyme and Sso6904, were isolated from a combinatorial library of Sso7d mutants using yeast surface display.